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Michał Pędziwiatr a, *, Mateusz Wierdak a, b, Mateusz Ostachowski c, Michał Natkaniec a,
Magdalena Białas d, Alicja Hubalewska-Dydejczyk e, Maciej Matłok a, Piotr Major a,
Piotr Budzynski a, Marcin Migaczewski a, Andrzej Budzynski a
a Jagiellonian University, 2nd, Department of General Surgery, Kopernika 21, 31-501 Krakow, Poland
b Jagiellonian University, Department of Physiology, Grzegorzecka 16, 31-531 Krakow, Poland
c Jagiellonian University, Department of Urology, Grzegorzecka 18, 31-531 Krakow, Poland
d Jagiellonian University, Department of Pathology, Grzegorzecka 16, 31-531 Krakow, Poland
e Jagiellonian University, Department of Endocrinology, Kopernika 16, 31-531 Krakow, Polandh i g h l i g h t s The outcomes of laparoscopic transperitoneal lateral adrenalectomy depend on the volume of the department.
 Gaining the experience with laparoscopic adrenalectomy reduces complication rate and shortens length of hospital stay.
 Involving surgery residents in training is associated with longer operative time but with no impact on clinical outcomes.a r t i c l e i n f o
Article history:
Received 1 January 2015
Received in revised form
4 May 2015
Accepted 2 June 2015
Available online 12 June 2015
Keywords:
Laparoscopic adrenalectomy
Learning curve
High volume center
Pheochromocytoma
Incidentaloma* Corresponding author.
E-mail address: michal.pedziwiatr@uj.edu.pl (M. P
http://dx.doi.org/10.1016/j.ijsu.2015.06.020
1743-9191/© 2015 The Authors. Published by Elsevier
creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
Introduction: Although laparoscopic adrenalectomy is considered relatively safe, the results of treatment
vary depending on the profile of the hospital. We would like to present our experience with laparoscopic
surgery of the adrenals.
Methods: We conducted a retrospective cohort study of consecutive patients operated for adrenal tu-
mours in the years 2003e2014. The study group included 175 (35%) men and 325 (65%) women. The
entire group was divided into 4 cohorts of 125 consecutively operated patients. Primary outcomes were
operative measures (operative time, its correlation with tumour size, blood loss, conversion rate, use of
peritoneal drainage). Secondary outcomes were the intra- and postoperative complications (using the
Clavien-Dindo classification), histological type of the tumours and length of hospital stay.
Results: There were no differences between groups in terms of the size and location of the tumour. The
mean operative time in each group was 85.7; 83.7; 89.6; 104.6 min (p < 0.001). The operative time
correlated to the size of the tumour. There were no differences in the conversion rates as well as in the
blood loss. However, it was observed that the complication rate was declining in subsequent subgroups
(14.4%, 11.2%, 8% and 5.6%, respectively, p ¼ 0.013). Length of hospital stay was 4.9 days, 3.9 days, 2.9 days,
2.4 days, respectively (p < 0.001).
Conclusion: The results of laparoscopic adrenalectomy depend not only on the experience of the single
surgeon, but on the whole team involved in perioperative care. In high volume centers with extensive
experience in surgery of adrenals, this technique may provide an alternative to open surgery, also in
selected cases of malignant tumours.
© 2015 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Limited. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ędziwiatr).
Ltd on behalf of IJS Publishing Group Limited. This is an open access article under the CC BY-NC-ND license (http://
Table 1
Hormonal activity of the tumour.
Nonfunctioning adrenal tumour 198 (39.6%)
Catecholamine-secreting tumour 137 (27.4%)
Glucocorticosteroid-secreting tumour 77 (15.4%)
Aldosterone-secreting tumour 59 (11.8%)
Adrenal metastasis 23 (4.6%)
Virilizing tumour 6 (1.2%)
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The first laparoscopic adrenalectomy was described in 1992 by
Michel Gagner [1]. As it soon turned out, the new surgical access
implies a number of advantages: early recovery, lower complication
rate, reduced postoperative pain, better cosmetic effect, and
improved access to the operated area [2,3]. In the initial stage of its
introduction, laparoscopy was only used to remove small ade-
nomas, but the indications gradually extended to bigger lesions;
therefore, it has quickly become the gold standard for the treatment
of all benign adrenal tumours [3e6]. Improving the quality of im-
aging and the popularity of laparoscopy resulted in the constantly
growing number of laparoscopic adrenalectomies performed
worldwide [7]. In the 1990s, most of high-volume laparoscopic
adrenal units developed either from pre-existing endocrine surgery
or urology departments, in which laparoscopic surgery has not yet
been performed or, alternatively, laparoscopic units extended their
field of interest into minimally invasive adrenal surgery. Although
this procedure is considered relatively safe, the presented treat-
ment results vary depending on the hospital's profile [4], and may
be affected by such factors, as a surgeon's experience in the treat-
ment of patients with adrenal pathology, as well as the number of
adrenalectomies performed annually. We would like to present our
experience with developing a high-volume laparoscopic adrenal
centre on the basis of awell-establishedminimally invasive surgery
department, over the last 11 years.
2. Methods
Our department is a part of a tertiary referral university hospital.
A retrospective cohort study, using a prospectively collected data-
base, included consecutive patients operated for adrenal tumours
in the years 2003e2014. The indication for surgery was either a
hormonally active tumour, or, in the case of non-secreting inci-
dentaloma, size 40 mm, rapid growth in follow-up studies, or a
so-called radiological malignant phenotype of the tumour. Addi-
tionally, the study included patients operated for isolated metas-
tases, as well as those with suspected primary adrenal malignancy,
submitted to minimally invasive surgery. Patients under the age of
18 or undergoing open adrenalectomy were excluded from the
study. All patients underwent preoperative imaging studies (ul-
trasound, computed tomography (CT), magnetic resonance imaging
(MRI), or, if necessary, positron emission computed tomography
(PET). Prior to surgery, a routine panel of laboratory tests was car-
ried out to establish the hormonal activity of the tumour. The
evaluation included plasma cortisol, urinary free cortisol, ACTH,
DHEAS, 17-OH-progesterone, testosterone, plasma renin activity, as
well as aldosterone, urinary aldosterone, catecholamines and
vanillylmandelic acid excretion. In cases of suspected pheochro-
mocytoma, patients were preoperatively treated with alpha-
blockers (doxazosin 20 mg/day, additional beta-blockers in case
of co-existing tachycardia) and intravenous volume expansionwith
crystalloids (2000 ml/day starting on the day before surgery). The
operative method of choice in our department is laparoscopic
transperitoneal lateral total adrenalectomy, which is performed
similarly to described elsewhere [1]. In cases of bilateral disease,
staged adrenalectomy was performed. The policy of our unit is to
always begin with laparoscopy (also in cases of highly suspected
cancer) and convert when safe and radical dissection is impossible.
During the study period, there was only one patient with 24 cm
tumour, who was initially submitted to open adrenalectomy. We
attempted the laparoscopic procedure in all remaining cases. For
the purpose of further analysis, the entire study population was
grouped into 4 cohorts of 125 consecutively operated patients. All
patients in group 1 were operated by the same experiencedlaparoscopic surgeon. Starting from group 2, procedures were
performed by other general surgery specialists (in the learning
curve of laparoscopic adrenalectomy) under his supervision,
whereas most patients in group 3 were operated without super-
vision. Finally, supervised senior residents in training operated
most patients from group 4. Primary outcomes were operative
measures (operative time, its correlation with tumour size, blood
loss, conversion rate, use of peritoneal drainage). Operative time
was measured from skin incision to closure; tumour size was
estimated in imaging studies (CT/MRI). The intraoperative blood
loss was measured from the amount of blood aspirated in the
suction machine. Secondary outcomes were the intra- and post-
operative complications (using the Clavien-Dindo classification),
histological type of the tumours removed and the length of hospital
stay [8].
Statistical analysis was performed using the Statsoft Statistica v.
10. Elements of descriptive statistics were used (mean, standard
deviation, percentage distribution). The analysis used the Cochran
Armitage trend test, KruskaleWallis test, Chi-square test and the
Pearson's correlation coefficient. Results were considered statisti-
cally significant when p-value was found to be less than 0.05.
3. Material
The study group included 175 (35%) men and 325 (65%) women.
The mean age was 54.9 years (18e87 years, SD ± 13.8 years). The
mean size of the removed lesion was 37.6 mm (7e160 mm,
SD ± 19.7 mm). The indication for surgery was a hormonally
inactive tumour in 198 (39.6%) patients, a catecholamine-secreting
tumour in 137 (27.4%) patients, a glucocorticosteroid-secreting
tumour in 77 (15.4%) patients, an aldosterone-producing tumour
in 59 (11.8%) patients, a virilizing tumour in 6 (1.2%) patients, and
metastasis to the adrenal gland in 23 (4.6%) patients (Table 1). The
annual number of adrenalectomies performed in the following
years is shown in Graph 1.
4. Results
The demographics of the analysed subgroups are shown in
Table 2.
The obtained data showed statistically significant differences in
the mean age (p ¼ 0.007). Additionally, there were no statistical
differences between groups in terms of the sex, size and location of
the tumour (right/left side).
The mean operative time in each group was 85.7; 83.7; 89.6;
104.6 min, respectively. We noticed a statistically significant dif-
ference between the groups - the shortest operative time was
observed in group 2, and the longest in group 4 (p < 0.001, Fig. 1).
It was observed that the operative time correlated to the size of
the tumour (p < 0.001, Fig. 2).
Conversion was necessary in a total of 7 patients (3 patients in
group 1 and two in the groups 2 and 3 each. The reasons for con-
version are presented in Table 3.
The differences in the conversion rates were not statistically
significant (p ¼ 0.431). The mean blood loss in the whole study
Fig. 1. Mean operative times in subsequent groups. Fig. 3. Mean intraoperative blood loss in subsequent groups.
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significant differences between the groups (p ¼ 0.241, Fig. 3).
A total of 11 (2.2%) patients required blood transfusions. A
summary of results is presented in Table 4.
It was observed, however, that the complication rate was
declining in subsequent groups (14.4%, 11.2%, 8% and 5.6%, respec-
tively). Statistical differences between groups were observed
(p ¼ 0.013). A detailed analysis of the types and rates of compli-
cations is shown in Tables 5 and 6. Readmissionwithin 30 day after
surgerywas necessary in 2 patientse one from group 2 (pulmonary
embolism) and the other from group 3 (pneumonia, p ¼ 0.205).
Relaparoscopy due to postoperative bleeding was necessary in
two cases. One death was reported in the study group e a patient
with pheochromocytoma (ASA grade 4) died seven days afterFig. 2. Correlation of the tumour size and thsurgery due to cardiopulmonary failure. When analysing the use of
peritoneal drainage, it was established that in group 1 it was used
routinely in all patients. In later periods this frequency decreased,
amounting to 85.6%, 24%, 3.2%, respectively (p < 0.001). The length
of hospital stay varied significantly, depending on the period in
which the surgery was performed. In group 1, it was 4.9 days, in
group 2e3.9 days, in group 3e2.9 days and in group 4e2.4 days
(p < 0.001).
The most common histological type of lesions removed was
adenoma - 187 (37,4%) patients, and nodular hyperplasia - 103
(20,3%) patients. In 98 (19.6%) cases postoperative pathologic
evaluation confirmed the diagnosis of pheochromocytoma, of
which 16 (11.2%) had the PASS score (Pheochromocytoma of Ad-
renal Gland Scaled Score) equal to or greater than 6. 23 (4.6%)e operative time (Pearson correlation).
Graph 1. The annual number of adrenalectomies performed in the following years.
Table 2
Demographics of the analysed groups.
Group 1 (patients 1e125) Group 2 (patients 126e250) Group 3 (patients 251e375) Group 4 (patients 376e500) p value
Age (years) 51.6 (SD ± 15.4) 54.5 (SD ± 11.2) 55.3 (SD ± 14.0) 58.1 (SD ± 13.6) 0.007a
Sex distribution
Women 84 (67.2%) 93 (74.4%) 67 (53.6%) 81 (64.8%) 0.142b
Men 41 (32.8%) 32 (25.6%) 58 (46.4%) 44 (35.2%)
ASA (American Society of Anaesthesiologists) grade
ASA 1 15 (12.0%) 7 (5.6%) 10 (8.0%) 13 (9.6%) 0.638b
ASA 2 68 (54.4%) 80 (64.0%) 70 (56.0%) 71 (56.8%)
ASA 3 37 (29.6%) 36 (28.8%) 42 (33.6%) 39 (31.2%)
ASA 4 5 (4.0%) 2 (1.6%) 3 (2.4%) 2 (1.6%)
Side
Right 61 (48.8%) 58 (46.4%) 62 (49.6%) 60 (48%) 0.968b
Left 64 (51.2%) 67 (53.6%) 63 (50.4%) 65 (52%)
Tumour size (mm) 38.9 (SD ± 18.1) 39.1 (SD ± 21.8) 32.7 (SD ± 18.3) 39.5 (SD ± 20.0) 0.520a
Benign/malignant 118 (94.4%)/7 (5.6%) 113 (90.4%)/12 (9.6%) 118 (94.4%)/7 (5.6%) 115 (92.0%)/10 (8.0%) 0.540b
Functioning/non-functioning 78 (62.4%)/47 (37.6%) 75 (60.0%)/50 (40.0%) 68 (54.4%)/57 (45.6%) 81 (64.8%)/44 (35.2%) 0.374b
a Kruskall-Wallis analysis of variance.
b Chi-square test.
Table 3
Reasons for conversion.
Definitive diagnosis Size Reason for conversion
1. Pheochromocytoma 67 mm hemodynamic instability, abnormal location of the tumour
2. Metastasis (Non-small cell lung cancer) 80 mm infiltration to adjacent organs
3. Pheochromocytoma 50 mm infiltration of the abdominal wall
4. Adrenocortical cancer 160 mm damage of the tumour capsule
5. Metastasis (Renal cell cancer) 88 mm adhesions after previous surgery
6. Adrenocortical cancer 120 mm adhesions after previous surgery
7. Pheochromocytoma 120 mm uncontrolled bleeding
Table 4
Results of surgery in subsequent groups.
Group 1 (patients 1e125) Group 2 (patients 126e250) Group 3 (patients 251e375) Group 4 (patients 376e500) p Value
Operative time (min.) 85.7 (SD ± 37.0) 83.7 (SD ± 29.7) 89.6 (SD ± 29.8) 104.6 (SD ± 34.9) <0.001a
Intraoperative blood loss (ml) 64.8 (SD ± 117.9) 68.3 (SD ± 153.0) 74.6 (SD ± 129.8) 84.3 (SD ± 151.4) 0.241a
Post-operative drainage 125 (100%) 107 (85.6%) 30 (24%) 4 (3.2%) <0.001b
Conversion 3 (2.4%) 2 (1.6%) 2 (1.6%) 0 (0%) 0.126b
Reoperation 1 (0.8%) 1 (0.8%) 0 (0%) 0 (0%) 0.205b
Length of stay (days) 4.88 (SD ± 1.68) 3.88 (SD ± 1.52) 2.97 (SD ± 1.10) 2.36 (SD ± 0.96) <0.001a
a Kruskall-Wallis analysis of variance.
b Cochran-Armitage trend test.
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Table 5
Intra- and postoperative complications in subsequent groups.
Group 1
(patients 1e125)
Group 2
(patients 126-250
Group 3
(patients 251e375)
Group 4
(patients 376e500)
Intraoperative complications
Intraoperative bleeding (blood loss of more than 300 ml) 7 (5.6%) 6 (4.8%) 6 (4.8%) 5 (4%)
Damage to the inferior vena cava 1 (0.8%) 1 (0.8%) 2 (1.6%) e
Damage to adjacent organs (spleen, kidney, liver, diaphragm) 3 (2.4%) 1 (0.8%) 1 (0.8%) 2 (1.6%)
Postoperative complications
Clavien-Dindo grade 1 5 (4%) 3 (2.4%) 2 (1.6%) 1 (0.8%)
Clavien-Dindo grade 2 4 (3.2%) 2 (1.6%) e 1 (0.8%)
Clavien-Dindo grade 3 2 (1.6%) 1 (0.8%) e e
Clavien-Dindo grade 4 e 1 (0.8%) 2 (1.6%) e
Clavien-Dindo grade 5 e e e 1 (0.8%)
Total number of patients with complications 18 (14.4%) 14 (11.2%) 10 (8%) 7 (5.6%)
The number of complications does not add up because some patients developed more than one complication.
Cochran-Armitage trend test e p ¼ 0.013.
Table 6
Number and types of postoperative complications in the study group.
Surgical site infection 5 (1%)
Wound hematoma 3 (0.6%)
Intraperitoneal hematoma (requiring percutaneous drainage) 1 (0.2%)
Lymphorrhoea 1 (0.2%)
Hemodynamic instability (requiring ICU admission) 3 (0.6%)
Pneumonia 3 (0.6%)
Deep vein thrombosis 1 (0.2%)
Postoperative intraperitoneal bleeding (requiring relaparoscopy) 2 (0.4%)
Pleural effusion (requiring percutaneous drainage) 1 (0.2%)
Pulmonary embolism 1 (0.2%)
Respiratory failure (requiring ICU admission) 1 (0.2%)
Subarachnoid hemorrhage 1 (0.2%)
Mortality 1 (0.2%)
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kidney and lung cancer). 13 (2.6%) patients were diagnosed with
primary malignancy of the adrenal gland (adrenal carcinoma in 12
patients, and primary neuroectodermal tumour in 1 patient). A
detailed analysis of histological types of changes is presented in
Table 7.
In the group of 36 patients with malignant adrenal tumours
(primary and metastatic), microscopic examination confirmed a R0
resection in 28 (77.8%) patients, and a R1 resection in 6 (16.7%). 2
patients underwent R2 resection (5.5%).Table 7
Analysis of histological types of removed tumours.
Histological type of the tumour n %
Adenoma 187 37,4
Nodular hyperplasia 103 20,6
Pheochromocytoma 98 19,6
Metastasis 23 4,6
Cystis 18 3,6
Myelolipoma 18 3,6
Adrenocortical cancer 12 2,4
Oncocytic adenoma 9 1,8
Pseudocystis 8 1,6
Haemangioma 6 1,2
Ganglioneuroma 4 0,8
Adrenal gland 3 0,6
Schwannoma 3 0,6
Angiomyolipoma 3 0,6
Primitive neuroectodermal tumour 1 0,2
Neurofibroma 1 0,2
Paraganglioma 1 0,2
Accesory spleen 1 0,2
Pancreas 1 0,2
Total 500 1005. Discussion
The analysis we have presented includes one of the largest
published groups of patients with adrenal gland tumour operated
in a single centre. We have been performing laparoscopic pro-
cedures of adrenal tumours as our initial method of choice for over
11 years. This paper is therefore a summary of long-term obser-
vations on the establishment and functioning of the centre for
surgical treatment of adrenal pathology, deriving from a laparo-
scopic surgery. It was observed that, despite unchanged surgical
technique, there were some changes in treatment, especially in
terms of factors influencing the length of hospital stay and com-
plications. Over the past decade, major changes occurred in the
diagnosis of adrenal tumours worldwide, associated with improved
access to diagnostic methods, the introduction of new methods of
anaesthesia and improvements in perioperative care [9]. In general,
this was reflected in the improvement in outcomes [10].
Before the era of laparoscopy, adrenalectomy was hardly ever
performed in our department. The fact that we began to perform
laparoscopic adrenalectomy had quickly convinced the local en-
docrinologists and surgeons to our unit. At the time, we were the
only centre in the southern part of the country that would perform
this type of procedure. Thus, in the first year of our activity, our
team has already operated over 20 patients, with the numbers
growing steadily to a level of 50e60 adrenalectomies annually in
subsequent years.
While analysing the subsequent periods of time, we noticed the
operative times were different with an unchanged mean size of the
tumour. Initially, the operative time was shorter, because the oper-
ations were performed by the same experienced laparoscopic sur-
geon (whose overall volume was more than 250 laparoscopic
adrenalectomies). Later, most of the procedures were performed by
other surgeons, and recently also by residents under the supervision
of experienced specialists. This resulted in a longer operative time.
Presently our department hires 5 independent laparoscopic adrenal
surgeons. Simply put, training has an obvious impact on our opera-
tive time. It is estimated that the learning curve of laparoscopic
adrenalectomy is approximately 20e40procedures [6e8]. Due to the
profile of our department, which is one of the largest teaching units
in the country (12 residencies), we do not expect themean operative
time to shorten. It should however be noted, that the results we
presented for the last two groups (the time from skin incision to
closure), although longer than in groups 1 and 2, are still comparable
to (or slightly shorter than) those described in other studies [4,11,12].
Wehave further observed that operative time is significantlyaffected
by the size of the tumour,which seems to be obvious considering the
anatomical conditions and surgical technique. Importantly, this does
not appear to have any effect on the clinical outcomes.
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with a relatively low risk of complications (1,8e15%) and negligible
mortality (below 0.5%) [4,13,14]. As in most surgical procedures,
however, the safety of the operation depends mainly on the
experience of the team performing the procedure. Although most
procedures are now performed by trainees under supervision, the
rate of perioperative complications was reduced in comparison to
the first period (14.4%, 11.2%, 8%, and 5.6%, respectively). It can
therefore be concluded, that the experience of the laparoscopic
centre is what translates primarily into the complication rate.
Similar observations are provided by the results of multicentre
trials including larger groups. The authors clearly show that the
complication rate and mortality is lower in high-volume hospitals
(more than 40 adrenalectomies per year) [15,16]. Better results are
also achieved by surgeons who operate adrenal tumours regularly
[17]. Due to the large number of cases each year, we are able to offer
the highest level of training to residents, providing them with
continuity of practice.
In the material we presented, the total conversion rate was 1.4%
and was comparable to that in other reports [4,13]. It was similar in
all the analysed periods. The most common cause for conversion in
our study was the oncological issue (inability of radical dissection)
which differs from the reports of other authors, where the most
common cause for conversion was uncontrolled bleeding [4,13].
Opinions on laparoscopic surgery for oncological indications are
inconclusive. While most authors agree it is a good alternative in
case of metastases, one may quite often hear an opinion that sus-
pected adrenal cancer should be a contraindication to laparoscopy
[18e21]. However, if we look at the indications for adrenalectomy
due to incidentaloma, the main argument for surgery is the risk of
co-occurrence of early cancer. If we strictly adhere to those criteria,
we should consider open surgery in all cases (as every suspected
cancer should be submitted to open surgery). Unfortunately, based
on preoperative studies, we are never certainwhether or not we are
dealing with cancer. Of the 13 patients with primary malignant
adrenal tumours, a high probability of cancer was only found
among 5. In the remaining 8 patients, diagnosis was only confirmed
with histopathological evaluation. In our opinion, laparoscopy is
merely a method of access, and oncological results do not depend
on the type of method used, but on appropriate surgical technique.
The results of studies comparing laparoscopic and open procedures
for cancers in other locations have shown they are comparable
oncologically [22e24]. Some studies of the adrenal glands show
similar results [7,25]. We believe that in most cases, a team expe-
rienced in laparoscopy and adrenal surgery is able to perform
radical removal of a tumour in compliance with all the principles of
oncological surgery, even in cases where a resection of adjacent
organs (liver, spleen) or extended lymphadenectomy is necessary.
We do not, however, support laparoscopic surgery at all costs.
Conversion was necessary in 2 (8.7%) out of 23 patients with me-
tastases to the adrenal glands and 2 (18.1%) patients with adrenal
carcinoma. A minimally invasive technique allows for excellent
staging, and for that reason beginning with laparoscopy seems
reasonable. In the hands of an experienced surgeon, it allows for
radical dissection in a similar proportion as the open access [7].
Conversion and the occurrence of intraoperative complications
are associated with increased intraoperative blood loss [15,26]. In
our study, the mean value was 74ml, and there was no difference in
the subsequent groups. The greatest blood loss was observed in
patients with damaged large veins (inferior vena cava three times,
renal vein once - sutured laparoscopically). Due to the significant
intraoperative blood loss and postoperative bleeding requiring
relaparoscopy, 11 (2.2%) patients required transfusion of blood
products. This data is similar to the results presented in other
studies [13].Routine care after open surgery involved postoperative
drainage. We have adopted this principle in the early period of
laparoscopy. The analysis by Major et al. shows drainage after
laparoscopic adrenalectomy is not only unnecessary, but may also
be associated with an increased risk of complications [27]. Over the
whole study period, we have almost entirely given up the use of
drains, only leaving them in the case of increased risk of post-
operative bleeding. Abandoning this procedure had a positive effect
on shortening the length of hospital stay. In the first period, it
amounted to nearly 5 days and was later shortened to 2.4 days.
Presently, a large part of patients is discharged the next day after
surgery. This is related to the established enhanced recovery after
surgery protocol with clearly defined discharge criteria that allow
the optimization of perioperative care, without affecting its quality.
Anaesthesia involves short-acting drugs, which reduces the risk of
side effects such as nausea and vomiting. Upon returning from the
recovery room, patients are immediately mobilized, and full hos-
pital diet is introduced within the first 12 h post-operation. We rely
on multimodal non-opioid analgesia and local bupivacaine infil-
tration to trocar insertion sites. This makes next day discharge
possible. We noticed the length of stay in the group 4 is shorter
than in other studies, but we did not observe any serious conse-
quences related to shorter hospital stay. According to some authors,
it is completely safe for the patient [28,29].
Our study is bound by certain limitations typical for a single
centre retrospective analysis. However, it is one of the largest
published groups of patients undergoing laparoscopic adrenalec-
tomy in one unit. Secondly, we have very quickly become a referral
centre for adrenal pathologies, which resulted in large number of
adrenalectomies performed annually. Therefore, our results cannot
be directly transferred to all kinds hospitals. Another limitation is
the fact that in this analysis we did not include potential post-
operative complications that might have occurred later than 30
days after discharge. This could certainly influence the overall
complication rate.
6. Summary
In our opinion, laparoscopic adrenalectomy, which is currently
the gold standard for treatment of adrenal tumours, is a safe
method associated with a low risk of perioperative complications
and negligible mortality. The results of the treatment do not
depend on the experience of a single surgeon, but on that of the
whole team involved in perioperative care. In high volume centres
with extensive experience in surgery of adrenals, this technique
may provide an alternative to open surgery, also in the case of
malignant tumours. However careful patient selection, along with a
well trained team is critical to improve outcomes.
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